Table 4.
rTEG® Trigger Value | ROTEM® Trigger Value | Intervention |
---|---|---|
ACT > 128 s | EXTEM CT > 80 s | PCC/FFP |
α-angle < 65° MAff/CFF < 11 mm |
EXTEM α-angle < 63° FIBTEM CA10 < 7 mm |
fibrinogen/cryoprecipitate |
MA < 55 mm | MCF < 45 mm | fibrinogen/cryoprecipitate/platelets |
LY30/60 > 7.5% 1 citrated TEG/r-TEG |
EXTEM CLI30/60 < 82% ML > 15% 1 |
TXA/aminocaproic acid |
Abbreviations: Activated clotting time (ACT); clot amplitude at 10 min (CA10); clot lysis index 60 min after CT (CLI60); clotting time (CT); extrinsic activator thromboelastometry (EXTEM); fresh frozen plasma (FFP); fibrin-based thromboelastometry (FIBTEM); lysis at 30 min (LY30); maximum amplitude (MA); TEG functional fibrinogen (MAff/CFF); maximum clot firmness (MCF); prothrombin complex concentrate (PCC); Maximum lysis after 30/60 min (ML30/60); rotational thromboelastometry (ROTEM®); RapidTEG® (rTEG®); thromboelastography (TEG®); tranexamic acid (TXA). 1 The values for LY30/60, CLI30/60, and ML as markers for clinically significant fibrinolysis vary significantly in the literature.